Stock Events

Stock Events

Dexcom 

$87.90
545
-$1.81-2.02% 20:00 Today
+$0.19+0.22%20:26After hours

Statistics

Day High
89
Day Low
87.65
52W High
92.59
52W Low
54.11
Volume
2,266,002
Avg. Volume
4,840,603
Mkt Cap
33.17B
P/E Ratio
32.17
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.32
0.45
0.57
0.7
Expected EPS
0.670402
Actual EPS
N/A

Financials

17.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.66BRevenue
836.3MNet Income

Analyst Ratings

88.65Average Price Target
The highest estimate is 96.00.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
88%
Hold
6%
Sell
6%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXCM. It's not an investment recommendation.
NVIDIA
141
NVDA
Amazon
134
AMZN
Apple
129
AAPL
Microsoft
121
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.49B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap493.31M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap104.16B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap54.55B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Show more...
CEO
Jacob Steven Leach
Employees
11100
Country
United States
ISIN
US2521311074
WKN
000A0D9T1

Listings

STU
DE
DC4.STU
MI
IT
1DXCM.MI
XETRA
DE
DC4.XETRA
MU
DE
DC4.MU

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of DXCM is $87.90 USD — it has decreased by -2.02% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Dexcom stocks are traded under the ticker DXCM.
Is Dexcom stock price growing?▼
DXCM stock has fallen by -3.22% compared to the previous week, the month change is a +1.1% rise, over the last year Dexcom has showed a +8.84% increase.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 33.17B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on October 22, 2026.
What were Dexcom earnings last quarter?▼
DXCM earnings for the last quarter are 0.7 USD per share, whereas the estimation was 0.61 USD resulting in a +14.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 4.66B USD.
What is Dexcom net income for the last year?▼
DXCM net income for the last year is 836.3M USD.
How many employees does Dexcom have?▼
As of September 04, 2026, the company has 11,100 employees.
In which sector is Dexcom located?▼
Dexcom operates in the Health & Wellness sector.
When did Dexcom complete a stock split?▼
The last stock split for Dexcom was on June 13, 2022 with a ratio of 4:1.
Where is Dexcom headquartered?▼
Dexcom is headquartered in SAN DIEGO, United States.